Back to today’s briefing

Story perspectives

New 'Quadruple-Action' Drug Promises 30% Weight Loss

9/3/2025

50 12

Summary

Story summary

Tufts University researchers are creating a 'quadruple-action' weight loss drug targeting four hormone receptors.
The drug may facilitate up to 30% weight loss, similar to bariatric surgery outcomes.
It seeks to enhance existing treatments like Ozempic and Mounjaro by targeting more receptors.
The new drug aims to minimize side effects and improve long-term weight maintenance.

1 of 1

Story summary

Tufts University researchers are creating a 'quadruple-action' weight loss drug targeting four hormone receptors.
The drug may facilitate up to 30% weight loss, similar to bariatric surgery outcomes.
It seeks to enhance existing treatments like Ozempic and Mounjaro by targeting more receptors.
The new drug aims to minimize side effects and improve long-term weight maintenance.